The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.
Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., ... & Demas, M. L. | Expert Review of Neurotherapeutics | 16 July 2019
Jaworska, N., & Phillips, J. L. | Cognitive neuroscience and neuroimaging | 1 July 2019
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto, K. | Psychiatry and Clinical Neurosciences | 19 June 2019
Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants.
Derntl, B., Hornung, J., Sen, Z. D., Colic, L., Li, M., & Walter, M. | Frontiers in neuroscience | 18 June 2019
Császár-Nagy, N., Kapócs, G., & Bókkon, I. | Reviews in the neurosciences | 2 April 2019
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Zheng, W., Zhou, Y. L., Liu, W. J., Wang, C. Y., Zhan, Y. N., Li, H. Q., & Ning, Y. P. | Journal of Psychopharmacology | 21 February 2019
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., ... & Tagliazucchi, E. | Consciousness and cognition | 1 February 2019
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019
Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019
Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
Yoon, G., Petrakis, I. L., & Krystal, J. H. | JAMA psychiatry | 9 January 2019
Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018
Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.
Getachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. | BMC microbiology | 22 December 2018
Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., ... & Reigstad, K. | Journal of child and adolescent psychopharmacology | 1 November 2018
Hirota, K. and Lambert, D. | British Journal of Anaesthesia | 12 October 2018 |
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., & Ning, Y.| Journal of Psychopharmacology | 27 September 2018
Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
Ionescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Johnson-Akeju, O., Swee, M. B., ... & Alpert, J. E. | Journal of Affective Disorders | 17 September 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness
Thomas, R. K., Baker, G., Lind, J., & Dursun, S. | Journal of psychopharmacology | 5 September 2018
Jones, J. L., Mateus, C. F., Malcolm, R. J., Brady, K. T., & Back, S. E. | Frontiers in Psychiatry | 24 July 2018